𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Cost-effectiveness analysis of interferon as adjuvant therapy in high-risk melanoma patients in Spain

✍ Scribed by J.L González-Larriba; S Serrano; M Alvarez-Mon; F Camacho; M.A Casado; J.L Dı́az-Pérez; E Dı́az-Rubio; L Fosbrook; V Guillem; J.J López-López; J.A Moreno-Nogueira; J Toribio

Book ID
117657022
Publisher
Elsevier Science
Year
2000
Tongue
English
Weight
147 KB
Volume
36
Category
Article
ISSN
0959-8049

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacokinetic/pharmacodynamic analysis
Pharmacokinetic/pharmacodynamic analysis of adjuvant pegylated interferon α-2b in patients with resected high-risk melanoma
✍ A. I. Daud; C. Xu; W.-J. Hwu; P. Urbas; S. Andrews; N. E. Papadopoulos; L. C. Fl 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 369 KB

## Purpose High-dose pegylated interferon α-2b (peginterferon α-2b) significantly decreased disease recurrence in patients with resected stage III melanoma in a clinical study. We investigated the pharmacokinetics (PK) and safety of high-dose peginterferon α-2b in patients with high-risk melanoma.